Evidence map›Paper›PMID 41417886›Full record

ArticleScience advances2025

Multicellular force coordination constructs microchannel networks for barrier-free metastasis across extracellular matrix.

Huan Gao, Bo Cheng, Guorui Jin, Yulong Han, Qi Tian, Yan Zhou, Xiwen Zhao, Yan Liu, Chunyu Cao, Lizhe Zhu and 7 more

Abstract read
In one paragraph

Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Huan GaoPhase I Clinical Trial Research Center, The First Affiliated Hospital of Xi'an Jiaotong University, Shaanxi 710061, P.R. China.ORCID 0000-0002-3954-4473
Bo ChengThe Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an 710049, P.R. China.ORCID 0000-0002-4913-1410
Guorui JinThe Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an 710049, P.R. China.ORCID 0000-0002-8494-9541
Yulong HanState Key Laboratory of Mechanics and Control of Mechanical Structures, Nanjing University of Aeronautics and Astronautics, Nanjing 210016, P. R. China.
Qi TianDepartment of Radiology, The First Affiliated Hospital of Xi'an Jiaotong University, Shaanxi 710061, P.R. China.
Yan ZhouPhase I Clinical Trial Research Center, The First Affiliated Hospital of Xi'an Jiaotong University, Shaanxi 710061, P.R. China.ORCID 0000-0002-3393-2440
Xiwen ZhaoDepartment of Cancer Center, The First Affiliated Hospital of Xi'an Jiaotong University, Shaanxi 710061, P.R. China.ORCID 0009-0004-8464-2402
Yan LiuThe Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an 710049, P.R. China.ORCID 0009-0008-2403-5271
Chunyu CaoThe Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an 710049, P.R. China.ORCID 0009-0004-8194-0340
Lizhe ZhuDepartment of Breast Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Shaanxi 710061, P.R. China.
Juan ZhangPhase I Clinical Trial Research Center, The First Affiliated Hospital of Xi'an Jiaotong University, Shaanxi 710061, P.R. China.ORCID 0000-0003-1780-8340
Lin WangEngineering Research Center of Personalized Anti-aging Health Product Development and Transformation, Universities of Shaanxi Province, Xi'an International University, Shaanxi 710077, P.R. China.
Binghe XuDepartment of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, P.R. China.ORCID 0000-0002-6863-5024
Hui GuoDepartment of Medical Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, P.R. China.ORCID 0000-0003-4412-3953
Min LinThe Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an 710049, P.R. China.ORCID 0000-0002-3259-1955
Jin YangPhase I Clinical Trial Research Center, The First Affiliated Hospital of Xi'an Jiaotong University, Shaanxi 710061, P.R. China.ORCID 0000-0002-2538-5176
Feng XuThe Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an 710049, P.R. China.ORCID 0000-0003-4351-0222

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The extracellular matrix (ECM) acts as a primary physical barrier to cancer metastasis. While individual cancer cells can remodel ECM to create microchannel-like paths of least resistance, this cell-centric view overlooks the coordinated dynamics of multicellular communication. Here, we reveal that cancer cells collaboratively reprogram ECM to construct interconnected microchannel networks functioning as "superhighways" for barrier-free metastasis. Combining live-cell imaging, atomic force microscopy, and optical tweezers, we decode that the indispensable step in microchannel network construction is organized cross-convergence of adjacent channels. The convergence is precisely directed by mechanical bridges composed of aligned collagen bundles between adjacent channels, which transmit orientation cues to induce multicellular force coordination. Integrating single-cell sequencing and off-lattice agent-based model, we identify mechanically responsive leader cells enriched for integrin-RhoA/YAP signaling and matrix metalloproteinase 14, which sense bridge cues and initiate cross-convergence. Collectively, our findings unveil a self-organized metastatic network and its mechanobiological mechanisms, offering a previously unidentified framework and potential therapeutic insights for cancer metastasis.

Indexed as

Extracellular MatrixCell Line, TumorCell MovementHumansMicroscopy, Atomic ForceNeoplasm MetastasisrhoA GTP-Binding ProteinSignal TransductionrhoA GTP-Binding Protein

Identifiers

PMID41417886
PMCPMC12716403

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.